Platelet Dysfunction Due to Drugs Clinical Trial
Official title:
The Impact of Various Storage Techniques on Platelet Function
Verified date | May 2019 |
Source | Northwell Health |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Platelet function will be tested in individuals on antiplatelet medications to determine the optimal storage methodology.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | July 15, 2020 |
Est. primary completion date | July 15, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Normal subjects Exclusion Criteria: - Pre existing antiplatelet drugs |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Northwell Health |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in platelet function | Frozen platelets will result in improvement in platelet function after transfusion. | 1 hour post-transfusion |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04206176 -
The Effects of loW Dose tIcagrelor on Platelet Function Testing in Patients With Stable Coronary arTery Disease
|
Phase 1/Phase 2 | |
Completed |
NCT02979158 -
Preoperative Dual Antiplatelet Therapy: Platelet Function and Influence of Cardiopulmonary Bypass
|
N/A | |
Completed |
NCT03603249 -
Trimetazidine as an Adjunct to Enhance Clopidogrel Response.
|
Phase 2 | |
Completed |
NCT03111420 -
Study of AggreGuide A-100 (ADP) Assay
|
N/A | |
Recruiting |
NCT03005704 -
Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets
|
N/A | |
Recruiting |
NCT06228820 -
Aspirin Resistance in Trinidad.
|
Phase 2 | |
Completed |
NCT04342819 -
The Effect of empagliFlozin on Platelet Function profilEs in diabetiC patienTs - The EFFECT Study.
|
Phase 2/Phase 3 | |
Completed |
NCT03121898 -
PLATelet Function Operating Room Monitoring
|
||
Active, not recruiting |
NCT03787927 -
Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets
|
Phase 1/Phase 2 | |
Withdrawn |
NCT02974777 -
The IDEAL-PCI Extended Registry
|
Phase 4 |